JNJ-9676
JNJ-9676 is a potent, orally bioavailable small molecule inhibitor targeting the transmembrane domain of the coronavirus membrane (M) protein dimer. By disrupting viral assembly, it demonstrates nanomolar antiviral efficacy against SARS-CoV-2 and SARS-CoV in vitro, supporting its utility as a research tool for studying coronavirus pathogenesis and therapeutic strategies.
Product Specifications
CAS Number
3026520-19-1
Product Name Alternative
JNJ9676
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology
Purity
99.83% (May vary between batches)
Solubility
DMSO:180 mg/mL (361.81 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:5 mg/mL (10.05 mM)
Smiles
C (NC1=CC (C#N) =CC=C1) (=O) C2=C3N (C[C@H] (C) N (C3=O) C4=CC=C (C (F) (F) C5=CC=CC=C5) C=C4) N=C2
Molecular Formula
C28H21F2N5O2
Molecular Weight
497.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Drd1 shRNA (UAS) - Lentiviral mouse Drd1 shRNA (UAS, GFP) plasmid
